https://www.corerxpharma.com/wp-content/uploads/2021/07/CoreRx-Investment.jpg
812
1030
Mark DaFonseca
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Mark DaFonseca2021-07-01 11:49:212021-07-01 13:31:29CoreRx Adds Investment to Expand Oral Dosage Form Capabilities
https://www.corerxpharma.com/wp-content/uploads/2021/06/CoreRx-Inc-names-Deborah-Wild-as-Executive-Chairwoman-of-the-Board.jpg
800
1200
Mark DaFonseca
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Mark DaFonseca2021-06-01 13:29:022021-06-07 10:07:50CoreRx, Inc. names Deborah Wild as Executive Chairwoman of the Board
https://www.corerxpharma.com/wp-content/uploads/2021/05/Nucleo3.jpg
812
1030
Mark DaFonseca
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Mark DaFonseca2021-05-24 11:36:592021-05-24 12:00:58CoreRx Acquires Nucleo Life Sciences
https://www.corerxpharma.com/wp-content/uploads/2021/04/Schedule-I-controlled-substances.jpg
812
1030
Mark DaFonseca
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Mark DaFonseca2021-04-30 13:34:302021-04-30 13:34:30CoreRx Inc. receives approval for Schedule I controlled drug manufacture
https://www.corerxpharma.com/wp-content/uploads/2020/04/Screen-Shot-2020-04-20-at-8.50.11-AM-e1601485420884.png
251
300
Devin Daviau
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Devin Daviau2020-08-03 18:46:292020-08-03 18:50:04CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER
https://www.corerxpharma.com/wp-content/uploads/2015/10/graph-lab.png
430
1500
Devin Daviau
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Devin Daviau2020-03-25 15:59:552020-03-25 16:41:26CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with long-standing client Bionpharma Inc.
https://www.corerxpharma.com/wp-content/uploads/2018/07/iStock_85158239_XXLARGE.jpg
3744
4748
Devin Daviau
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Devin Daviau2020-02-04 09:00:212020-02-04 13:36:14JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer for Phase 2b clinical formulation and development
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
0
0
Studio 98
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Studio 982019-10-28 17:13:582019-10-28 17:14:11CORERX, INC. ADDS PRODUCT DEVELOPMENT CENTER OF EXCELLENCE INCREASING PRODUCT DEVELOPMENT CAPACITY
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
0
0
Studio 98
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Studio 982019-09-12 14:07:322019-09-12 14:33:18Biotech Stock On The Radar: Aimmune Awaits Adcom Test
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
0
0
Devin Daviau
https://www.corerxpharma.com/wp-content/uploads/2016/05/logo-tag-1.png
Devin Daviau2019-05-13 12:10:042019-05-13 16:48:54CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics’ Investigational Peanut Allergy Treatment